XTX Topco Ltd Purchases New Position in Danaher Co. (NYSE:DHR)

XTX Topco Ltd purchased a new position in Danaher Co. (NYSE:DHR) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 1,829 shares of the conglomerate’s stock, valued at approximately $420,000.

Several other institutional investors have also bought and sold shares of the business. Heck Capital Advisors LLC bought a new position in shares of Danaher in the 4th quarter valued at about $27,000. Decker Retirement Planning Inc. bought a new position in shares of Danaher during the 4th quarter valued at approximately $31,000. Golden State Wealth Management LLC bought a new stake in Danaher in the fourth quarter worth $31,000. Strategic Financial Concepts LLC bought a new position in Danaher during the fourth quarter valued at $31,000. Finally, Pineridge Advisors LLC lifted its holdings in shares of Danaher by 63.3% in the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after acquiring an additional 57 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Danaher Trading Down 1.0 %

NYSE:DHR opened at $184.96 on Tuesday. Danaher Co. has a 12 month low of $171.00 and a 12 month high of $281.70. The company has a market capitalization of $132.19 billion, a P/E ratio of 35.03, a PEG ratio of 2.66 and a beta of 0.86. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The firm has a fifty day simple moving average of $201.64 and a 200-day simple moving average of $226.01.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter last year, the firm posted $2.09 earnings per share. On average, equities research analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be paid a dividend of $0.32 per share. The ex-dividend date is Friday, March 28th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.69%. This is a positive change from Danaher’s previous quarterly dividend of $0.27. Danaher’s dividend payout ratio (DPR) is presently 24.24%.

Insider Activity

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 11.10% of the company’s stock.

Analysts Set New Price Targets

Several analysts have issued reports on the stock. Robert W. Baird set a $231.00 price objective on shares of Danaher in a research note on Wednesday, April 16th. Stifel Nicolaus raised shares of Danaher from a “hold” rating to a “buy” rating and set a $260.00 price target on the stock in a research note on Friday, March 14th. Barclays raised shares of Danaher from an “equal weight” rating to an “overweight” rating and reduced their target price for the stock from $240.00 to $205.00 in a research report on Thursday, April 10th. Wells Fargo & Company reduced their price objective on Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a report on Thursday, January 30th. Finally, The Goldman Sachs Group upgraded Danaher from a “neutral” rating to a “buy” rating and set a $260.00 price target on the stock in a research note on Friday, March 21st. Four analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $274.55.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.